1,656
Views
3
CrossRef citations to date
0
Altmetric
Review Article

New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production?

, , &
Pages 970-973 | Received 10 Dec 2013, Accepted 02 Apr 2014, Published online: 15 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eileen Samy, Stephen Wax, Bertrand Huard, Henry Hess & Pascal Schneider. (2017) Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. International Reviews of Immunology 36:1, pages 3-19.
Read now

Articles from other publishers (2)

Hana Ciferska, Eva Honsova, Alena Lodererova, Zdenka Hruskova, Michaela Neprasova, Jan Vachek, Miloslav Suchanek, Tomas Zima, Rosanna Coppo, Vladimir Tesar, Jan Novak & Dita Maixnerova. (2019) Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?. Journal of Nephrology 33:2, pages 307-316.
Crossref
Jakub Ruszkowski, Katarzyna A. Lisowska, Małgorzata Pindel, Zbigniew Heleniak, Alicja Dębska-Ślizień & Jacek M. Witkowski. (2018) T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target. Clinical and Experimental Nephrology 23:3, pages 291-303.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.